Next Article in Journal
Methyl 6-Methyl-1-(4-methylphenyl)-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Previous Article in Journal
4-[(2-Hydroxy-4-pentadecylbenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

N-(2-Phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methane Sulfonamide

by
Shylaprasad Durgadas
1,2,
Khagga Mukkanti
2 and
Sarbani Pal
3,*
1
Centre for chemical Sciences and Technology, Institute of Science & Technology, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad-500085, Andhra Pradesh, India
2
MSN Pharmachem Pvt. Ltd., Plot No 212/A,B,C,D, APIICL, Phase –II, Pashamylaram, Patancheru (M), Medak District 502307, Andhra Pradesh, India
3
MNR Degree & PG College, Kukatpally, Hyderabad-500085, Andhra Pradesh, India
*
Author to whom correspondence should be addressed.
Molbank 2012, 2012(1), M751; https://doi.org/10.3390/M751
Submission received: 7 February 2012 / Accepted: 29 February 2012 / Published: 2 March 2012

Abstract

:
The title compound, N-(2-phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methanesulfonamide was synthesized in high yield by Sonogashira cross coupling of N-(4-iodo-2-phenoxyphenyl)methanesulfonamide with 3-phenoxyprop-1-yne. The structure of the compound was fully characterized by IR, 1H and 13C NMR, Mass spectra and elemental analysis.

Graphical Abstract

The disubstituted alkynes have long been of interest because of their numerous applications and uses in synthetic organic chemistry, molecular electronics and pharmacology. They mainly exhibit anti bacterial and anti cancer activities [1]. On the other hand, compounds containing sulfonamide moiety e.g., 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) showed enhanced cytotoxic effects of doxorubicin on HKESC-1 and HKESC-2 cells [2]. Nimesulide B (Figure 1), a sulfonamide based well known antiinflamatory agent, is presently in patient’s use in certain countries. Because of their common cytotoxic properties and our interest in nimesulide (N-(4-nitro-2-phenoxy phenyl)methane sulfonamide) derivatives [3,4,5,6,7,8,9,10] as potential cytotoxic agents, we designed the appropriately functionalized hybrid molecule C containing structural features of both A and B (Figure 1).
The alkynylation of iodoarenes via C-C bond forming reaction under Pd-Cu catalysis (the Sonogashira coupling) [11] has found wide applications in organic synthesis [12]. The methodology offers a very convenient, mild and one-step process for the direct coupling of terminal alkynes with iodoarene to provide the desired internal alkynes. This methodology was adopted for the preparation of our target molecule C (or 3) and the corresponding synthesis is shown in Scheme 1.
The starting compound 1 required for our study was prepared in quantitative yield from nimesulide (B) via reduction of its nitro group to primary amine followed by conversion of the amine moiety to an iodo goup under a Sandmeyer reaction condition. The Sonogashira cross-coupling was then employed to form a carbon–carbon bond between the aryl iodide (1) and the terminal alkyne (2). The reaction was carried out under mild conditions.
In the 1H-NMR spectrum (DMSO-d6) of compound 3, two characteristic singlets appeared at 3.03 and 4.97 ppm were due to the methyl and methylene group respectively. The singlet of NH group appeared at 9.59 ppm, which was confirmed by its disappearance during D2O exchange experiment. Moreover, the two characteristic signals of acetylenic carbon atoms appeared in the 13C-NMR spectrum of compound 3 at 85.8 and 84.5 ppm. The fact was also supported by the mass spectrum of compound 3 which showed molecular ion peak (M+) at m/z 394.1. The analytical data was in complete agreement with the molecular formula C22H19NO4S.
N-(4-iodo-2-phenoxyphenyl) methane sulfonamide (1), (1.945 g, 5 mmol) in 20 mL acetonitrile was added diisopropylethyl amine (0.969 g, 7.5 mmol), Pd(OAc)2 (125 mg, 0.5 mmol) and CuI (0.50 mmol). The mixture was stirred for 15 min at room temperature then added prop-2-ynyloxybenzene (2, 0.792 mg, 6 mmol) followed by reflux for 10–12 h. The progress was confirmed by checking TLC in regular intervals. After completion of reaction, the crude was distilled under reduced pressure and the compound, 3 was purified by column chromatography by using cyclohexane:EtOAc = 9.5:0.5.
Description of the compound: Off white crystalline solid.
Yield: 80%.
Mp: 98–102 °C.
Rf: 0.5 (Cyclohexane:EtOAc = 9.5:0.5).
IR υmax (KBr cm−1): 3292, 2231, 1573, 1588, 1509, 1489.
Mass (ES): m/z 394.1(M+1, 100%).
1HNMR (400 MHz, DMSO-d6): δ 3.03 (s, 3H), 4.97(s, 2H), 6.81 (d, 1H, J 2 Hz), 7.00–6.94 (m, 3H), 7.08–7.06 (m, 2H), 7.31–7.19 (m, 4H), 7.46–7.41 (m, 3H), 9.59 (1H, NH, D2O exchangeable).
13C NMR (75 MHz, DMSO-d6): δ 39.7 (CH3), 56.4 (OCH2), 84.5 (acetylenic C), 85.8. (acetylenic C), 114.8 (2CH), 119.0 (2CH), 119.1 (C), 120.2 (CH), 120.7 (CH), 121.4 (CH), 124.7 (CH), 127.7 (CH), 128.6 (C), 129.4 (2CH), 130.2 (2CH), 146.7 (C), 155.2 (C), 157.6 (C).
Anal. calc. for C22H19NO4S: C, 67.16; H, 4.87; N, 3.56, Found: C, , 67.38; H, 4.76; N, 3.39.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgments

The author (S. Pal) thanks Mr. M. N. Raju, the chairman of M. N. R. Educational Trust for his constant encouragement.

References

  1. Yu, L.; Wu, W.K.; Li, Z.J.; Liu, Q.C.; Li, H.T.; Wu, Y.C.; Cho, C.H. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity. Mol. Pharmacol. 2009, 75, 1364–1373. [Google Scholar] [CrossRef] [PubMed]
  2. Roberts, L.J.; Morrow, J.D. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics; Hardman, J.G., Limbird, L.E., Eds.; McGraw-Hill: New York, NY, USA, 2001; pp. 687–731. [Google Scholar]
  3. Pericherla, S.; Mareddy, J.; Rani, D.P.G.; Gollapudi, P.V.; Pal, S. Chemical modifications of nimesulide. J. Braz. Chem. Soc. 2007, 18, 384–390. [Google Scholar] [CrossRef]
  4. Reddy, L.V.; Nakka, M.; Suman, A.; Ghosh, S.; Helliwell, M.; Mukkanti, K.; Mukherjee, A.K.; Pal, S. Synthesis of novel quinoline analogues of nimesulide: An unusual observation. J. Heterocycl. Chem. 2011, 48, 555–562. [Google Scholar] [CrossRef]
  5. Durgadas, S.; Chatare, V.K.; Mukkanti, K.; Pal, S. Palladium-mediated synthesis of novel nimesulide derivatives. Appl. Organometal. Chem. 2010, 24, 680–684. [Google Scholar] [CrossRef]
  6. Kankanala, K.; Reddy, V.R.; Mukkanti, K.; Pal, S. Lewis Acid Free High Speed Synthesis of Nimesulide-Based Novel N-Substituted Cyclic Imides. J. Braz. Chem. Soc. 2010, 21, 1060–1064. [Google Scholar] [CrossRef]
  7. Reddy, L.V.; Kethavath, M.; Nakka, M.; Beevi, S.S.; Mangamoori, L.N.; Mukkanti, K.; Pal, S. Design and synthesis of novel cytotoxic agents based on combined framework of quinoline and nimesulide. J. Heterocycl. Chem. 2012, 49, 80–87. [Google Scholar] [CrossRef]
  8. Pal, S.; Durgadas, S.; Nallapati, S.B.; Mukkanti, K.; Kapavarapu, R.; Meda, C.L.T.; Parsa, K.V.L.; Pal, M. Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): A new strategy to identify inhibitors of PDE4B. Bioorg. Med. Chem. Lett. 2011, 21, 6573–6576. [Google Scholar] [CrossRef] [PubMed]
  9. Bhattacharya, A.; Ghosh, S.; Kavitha, K.; Reddy, V.R.; Mukkanti, K.; Pal, S.; Mukherjee, A.K. Crystal structure and electronic properties of two nimesulide derivatives: A combined X-ray powder diffraction and quantum mechanical study. Chem. Phys. Lett. 2010, 493, 151–157. [Google Scholar] [CrossRef]
  10. Kavitha, K.; Varsha, P.; Mukkanti, K.; Reddy, V.R.; Pal, S. N-(4-Methylsulfonamido-3-phenoxyphenyl)-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboximide. Molbank 2011, 2011, M740. [Google Scholar]
  11. Sonogashira, K.; Tohda, Y.; Hagihara, N. A convenient synthesis of acetylenes: Catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines. Tetrahedron Lett. 1975, 16, 4467–4470. [Google Scholar] [CrossRef]
  12. Chinchilla, R.; Najera, C. The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry. Chem. Rev. 2007, 107, 874–922. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Design of hybrid molecule C from alkyne A and nimesulide B.
Figure 1. Design of hybrid molecule C from alkyne A and nimesulide B.
Molbank 2012 m751 g001
Scheme 1. Synthesis of the title compound C (or 3).
Scheme 1. Synthesis of the title compound C (or 3).
Molbank 2012 m751 sch001

Share and Cite

MDPI and ACS Style

Durgadas, S.; Mukkanti, K.; Pal, S. N-(2-Phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methane Sulfonamide. Molbank 2012, 2012, M751. https://doi.org/10.3390/M751

AMA Style

Durgadas S, Mukkanti K, Pal S. N-(2-Phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methane Sulfonamide. Molbank. 2012; 2012(1):M751. https://doi.org/10.3390/M751

Chicago/Turabian Style

Durgadas, Shylaprasad, Khagga Mukkanti, and Sarbani Pal. 2012. "N-(2-Phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methane Sulfonamide" Molbank 2012, no. 1: M751. https://doi.org/10.3390/M751

APA Style

Durgadas, S., Mukkanti, K., & Pal, S. (2012). N-(2-Phenoxy-4-(3-phenoxyprop-1-ynyl)phenyl)methane Sulfonamide. Molbank, 2012(1), M751. https://doi.org/10.3390/M751

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop